Heyholder
‹ Activism Filings

QuadMedicine Inc. Q3 operating loss of KRW 3.7 billion on revenue of KRW 25 million

QuadMedicine Inc.· Periodic Report

AI summary · Not investment advice

Quadmedicine sold KRW 25 million in Q3 and lost KRW 3.7 billion from its main business, versus sales of KRW 1.9 billion and a loss of KRW 2.6 billion a year earlier.

Operating profit · 3 months

KRW -3.7 billion

Key facts

Revenue (3 months)
KRW 25.0 million
Net income (3 months)
KRW -3.8 billion
Period
Q3 (cumulative Jan 1, 2026 ~ Sep 30, 2026)
Revenue (prior-year 3 months)
KRW 1.9 billion
Revenue (year to date)
KRW 1.8 billion
Operating profit (prior-year 3 months)
KRW -2.6 billion
Operating profit (year to date)
KRW -10.5 billion
Net income (prior-year 3 months)
KRW -2.6 billion
Net income (year to date)
KRW -10.7 billion

Commentary

AI commentary · Not investment advice

What happened

Quadmedicine filed its quarterly report for the third quarter, on a consolidated basis. Sales for the latest 3 months were KRW 25.0 million, down 98.7% from KRW 1.94 billion in the same period a year earlier.

In the company's terms

Operating profit (profit from the core business) for the latest 3 months was a loss of KRW 3.68 billion. A year earlier it was a loss of KRW 2.62 billion. Net income (the final profit after all costs and taxes) for the latest 3 months was a loss of KRW 3.77 billion. A year earlier it was a loss of KRW 2.65 billion.

What changes for shareholders

For the cumulative period from January 1 to September 30, sales were KRW 1.82 billion. Operating profit was a loss of KRW 10.47 billion, and net income was a loss of KRW 10.73 billion.

Comments

No comments yet

Comments from shareholders will appear here.